305 related articles for article (PubMed ID: 15015423)
1. Executive pay trends and golden parachute tax: a collision on the horizon.
Johnson DG
Benefits Q; 2004; 20(1):30-6. PubMed ID: 15015423
[TBL] [Abstract][Full Text] [Related]
2. Executive compensation in excess of $1 million: shareholder approval and corporate waste.
Kaderabek LM; Quinlan WJ
Benefits Q; 1995; 11(3):96-101. PubMed ID: 10151121
[TBL] [Abstract][Full Text] [Related]
3. Trying to compensate. Latest ranking of CEO compensation finds stock options still key to pay as experts monitor for effects of SEC rule changes.
Galloro V; Vesely R; Zigmond J
Mod Healthc; 2007 Jul; 37(30):6, 14, 16 passim. PubMed ID: 17824144
[TBL] [Abstract][Full Text] [Related]
4. Who should set CEO pay? The press? Congress? Shareholders?
Brownstein AR; Panner MJ
Harv Bus Rev; 1992; 70(3):28-32, 34-5, 38. PubMed ID: 10118002
[TBL] [Abstract][Full Text] [Related]
5. Expensing options solves nothing.
Sahlman WA
Harv Bus Rev; 2002 Dec; 80(12):90-6, 134. PubMed ID: 12510541
[TBL] [Abstract][Full Text] [Related]
6. New thinking on how to link executive pay with performance.
Rappaport A
Harv Bus Rev; 1999; 77(2):91-101, 186. PubMed ID: 10387774
[TBL] [Abstract][Full Text] [Related]
7. A comparison of executive incentive compensation in health care and general industry.
Freundt JF; Krotzer ME
Top Health Care Financ; 1989; 16(2):7-18. PubMed ID: 2617535
[No Abstract] [Full Text] [Related]
8. Are they worth it? Executive compensation, company performance don't always relate at top hospital, post-acute and insurance companies.
Galloro V; Benko LB
Mod Healthc; 2003 Aug; 33(31):6-7, 14, 1. PubMed ID: 12931471
[TBL] [Abstract][Full Text] [Related]
9. The "perfect storm" in compensation: convergence of events leads to a greater need to review compensation strategies.
Jones RB
Benefits Q; 2004; 20(1):17-22. PubMed ID: 15015421
[TBL] [Abstract][Full Text] [Related]
10. Value rules: senior management incentives in the post-option era.
Ericson R
Benefits Q; 2004; 20(1):23-9. PubMed ID: 15015422
[TBL] [Abstract][Full Text] [Related]
11. Employer executive compensation and benefits after the Tax Reform Act of 1986.
Zuckerman AE; Hranchak WH
Top Health Care Financ; 1988; 14(4):61-72. PubMed ID: 3413787
[No Abstract] [Full Text] [Related]
12. The new landscape: a fresh look at long-term incentives for corporate America.
Cates DC; Costelloe AM
Benefits Q; 2004; 20(1):7-16. PubMed ID: 15015420
[TBL] [Abstract][Full Text] [Related]
13. CEO pay: how much is enough?
Crystal GS; Whitworth RV; Mace ML; Kesner MS; Sabo MO; Lorsch JW; Sollman G; Minow N; Wallman SM; Holtzman E
Harv Bus Rev; 1992; 70(4):130-4, 136-9. PubMed ID: 10119717
[No Abstract] [Full Text] [Related]
14. Compensation of key administrative employees.
Top Health Care Financ; 1980; 7(2):59-67. PubMed ID: 7444956
[No Abstract] [Full Text] [Related]
15. What's wrong with executive compensation? A roundtable moderated by Charles Elson.
Roiter E; Clapman P; Heard J; Bachelder J; England J; Lau G; Woolard ES; Meyer P; Hall B; Barnette H; Batts W; Veasey EN
Harv Bus Rev; 2003 Jan; 81(1):68-77. PubMed ID: 12545924
[TBL] [Abstract][Full Text] [Related]
16. Minn., Calif. say no to exec perks. States question pay for UnitedHealth's CEO, directors.
Benko LB
Mod Healthc; 2006 May; 36(18):4. PubMed ID: 16689425
[No Abstract] [Full Text] [Related]
17. Leaving on a high note. AHA is flush as its president exits at the top of the heap in compensation.
DoBias M
Mod Healthc; 2006 Aug; 36(33):12-3. PubMed ID: 16967897
[No Abstract] [Full Text] [Related]
18. Closing the sale of a healthcare business.
Walker B; Cockrell G; Bushee M
Health Care Law Mon; 2012 Apr; 2012(4):2-5. PubMed ID: 22594004
[No Abstract] [Full Text] [Related]
19. Executive pay hide-and-seek. With the IRS poised to inspect compensation at tax-exempt not-for-profits, perks and benefits for hospital executives likely to get much closer attention.
Taylor M
Mod Healthc; 2004 May; 34(22):6-7, 16, 1. PubMed ID: 15202169
[TBL] [Abstract][Full Text] [Related]
20. Executive compensation at private biotech companies: beyond hearsay.
Rychlik B; DiPierro M
Nat Biotechnol; 2006 Dec; 24(12):1599-600. PubMed ID: 17160064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
